What does MEDISTRAT do?

MEDISTRAT is a market research agency in Lasne. Public Limited, started on 2 May 1995, 1 establishment.

What is the address of MEDISTRAT?

The registered office of MEDISTRAT is located at Route de Genval 32, 1380 Lasne.

Is MEDISTRAT still active?

Yes. According to the CBE (29 October 2026) MEDISTRAT is active, legal situation “Normale toestand”, started on 2 May 1995.

Is MEDISTRAT registered on Peppol?

Yes, MEDISTRAT is registered on the Peppol network with ID 0208:0455137658.

What is the enterprise number of MEDISTRAT?

The enterprise number of MEDISTRAT is BE0455137658.

When was MEDISTRAT founded?

MEDISTRAT was founded on 2 May 1995.

Who are the directors of MEDISTRAT?

According to the 2025 annual accounts, the directors of MEDISTRAT are: Purple SRL.

Is MEDISTRAT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 May 1995; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDISTRAT make in 2025?

MEDISTRAT posted a profit after taxes of € 39,586 in financial year 2025.

What is the revenue of MEDISTRAT?

As a small company, MEDISTRAT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 137,214.

MEDISTRAT (Public Limited) - Lasne - BE0455137658

Dossier MEDISTRAT, printed on 29 October 2026 from databakkes.be/en/0455137658/medistrat. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.
Busy address KBO

18 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

MEDISTRAT from Lasne, company number BE0455137658, closed financial year 2025 with a result of € 39,586 after tax. For that financial year MEDISTRAT recorded a gross margin of € 137,214 and equity of € 121,849. Compared with financial year 2024, the result moved from € 53,586 to € 39,586. The company is profitable. The buffer shrank hard: equity is 52 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Shrank hard

€ 121,849

▼ 52% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 39,586

▼ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 150,178

▲ 42% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 170,597 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 71,896

▲ 9% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,838

▲ 234% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 83

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 19,091

▲ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 51,295

▲ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,521 Gross margin 2022: € 115,521 First fiscal year in the series	€ 19,555 Gross margin 2023: € 19,555 ▼ 83% vs 2022 (€ 115,521) Unfavourable step	€ 131,982 Gross margin 2024: € 131,982 ▲ € 112,427 vs 2023 (€ 19,555) Favourable step	€ 137,214 Gross margin 2025: € 137,214 ▲ 4% vs 2024 (€ 131,982) Favourable step	▲ 4%
Profit after taxes	€ -18,627 Profit after taxes 2022: € -18,627 First fiscal year in the series	€ -48,317 Profit after taxes 2023: € -48,317 ▼ € 29,691 vs 2022 (€ -18,627) Unfavourable step	€ 53,586 Profit after taxes 2024: € 53,586 ▲ € 101,904 vs 2023 (€ -48,317) Favourable step	€ 39,586 Profit after taxes 2025: € 39,586 ▼ 26% vs 2024 (€ 53,586) Unfavourable step	▼ 26%
Equity	€ 297,591 Equity 2022: € 297,591 First fiscal year in the series	€ 249,274 Equity 2023: € 249,274 ▼ 16% vs 2022 (€ 297,591) Unfavourable step	€ 252,860 Equity 2024: € 252,860 ▲ 1% vs 2023 (€ 249,274) Favourable step	€ 121,849 Equity 2025: € 121,849 ▼ 52% vs 2024 (€ 252,860) Unfavourable step	▼ 52%
Total debts	€ 60,989 Total debts 2022: € 60,989 First fiscal year in the series	€ 130,228 Total debts 2023: € 130,228 ▲ 114% vs 2022 (€ 60,989) Unfavourable step	€ 123,214 Total debts 2024: € 123,214 ▼ 5% vs 2023 (€ 130,228) Favourable step	€ 257,727 Total debts 2025: € 257,727 ▲ 109% vs 2024 (€ 123,214) Unfavourable step	▲ 109%
Cash	€ 73,079 Cash 2022: € 73,079 First fiscal year in the series	€ 122,239 Cash 2023: € 122,239 ▲ 67% vs 2022 (€ 73,079) Favourable step	€ 106,051 Cash 2024: € 106,051 ▼ 13% vs 2023 (€ 122,239) Unfavourable step	€ 150,178 Cash 2025: € 150,178 ▲ 42% vs 2024 (€ 106,051) Favourable step	▲ 42%
Land & buildings	€ 10,935 Land & buildings 2022: € 10,935 First fiscal year in the series	€ 2,427 Land & buildings 2023: € 2,427 ▼ 78% vs 2022 (€ 10,935) Unchanged	€ 0 Land & buildings 2024: € 0 ▼ 100% vs 2023 (€ 2,427) Unchanged	-
Retained profit	€ 235,591 Retained profit 2022: € 235,591 First fiscal year in the series	€ 187,274 Retained profit 2023: € 187,274 ▼ 21% vs 2022 (€ 235,591) Unfavourable step	€ 190,860 Retained profit 2024: € 190,860 ▲ 2% vs 2023 (€ 187,274) Favourable step	€ 59,849 Retained profit 2025: € 59,849 ▼ 69% vs 2024 (€ 190,860) Unfavourable step	▼ 69%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged	€ 170,597 Dividend 2025: € 170,597 ▲ 241% vs 2024 (€ 50,000) Unchanged	▲ 241%
Bank debt	€ 11,849 Bank debt 2022: € 11,849 First fiscal year in the series	€ 2,451 Bank debt 2023: € 2,451 ▼ 79% vs 2022 (€ 11,849) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 2,451) Favourable step	€ 83 Bank debt 2025: € 83 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 358,580 Balance sheet total 2022: € 358,580 First fiscal year in the series	€ 379,502 Balance sheet total 2023: € 379,502 ▲ 6% vs 2022 (€ 358,580) Unchanged	€ 376,074 Balance sheet total 2024: € 376,074 ▼ 1% vs 2023 (€ 379,502) Unchanged	€ 379,577 Balance sheet total 2025: € 379,577 ▲ 1% vs 2024 (€ 376,074) Unchanged	▲ 1%

Key figures of MEDISTRAT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDISTRAT?

What happened at MEDISTRAT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: profit of € 39,586 (▼ 26% vs 2024). Source: NBB ↗
2014 Purple SRL became a director. NBB
May 19, 1995 New establishment in Lasne. KBO
May 2, 1995 Start of the company according to the CBE. KBO

In short

From € 18,627 loss in 2022 to € 39,586 profit in 2025.

Paid € 21,446 in corporate taxes since 2022.

Best year ever: 2024, with € 53,586 profit.

Paid out € 220,597 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PURPLE 100%

THEFACTORY 50%

The stake of PURPLE, THEFACTORY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDISTRAT

Behind MEDISTRAT is Purple SRL. The shares are held by PURPLE (100%) and THEFACTORY (50%).

Directors

According to the 2025 annual accounts

Purple SRL

Director · represented by Catherine Vanbever

since 2014

Shareholders

PURPLE

100%

THEFACTORY

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Route de Genval 32

1380 Lasne

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.

All companies at this address →

PEREBOOMS & Cie

€ 484,662 gross margin · 2025

AAKV - Architecture & Energie

€ 20,880 gross margin · 2025

Whitestone Group

€ 713,088 revenue · 2025

LE TRI VICHY

€ 17,568 gross margin · 2025

JOHN DOE GROUP

€ 6,163 gross margin · 2026

+13 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0455.137.658

VAT number

BE 0455.137.658

Registered office

Route de Genval 32, 1380 Lasne

Names & denominations

MEDISTRAT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

2 May 1995

Peppol

Active · Active since 30 Mar 2026

Activities · NACE

Markt- en opinieonderzoek

Marktonderzoekbureaus

Publiciteitsagentschappen

Activiteiten van reclamebureaus

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISTRAT

Warning lights

Financials

What happened to MEDISTRAT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions